Changes in ZAG levels are closely related to obesity [122] and the associated comorbidities such as diabetes, obesity, polycystic ovary syndrome [123,124], non-alcoholic fatty acid liver disease (NAFLD), etc. [125]. This evidence concerns the gene AZGP1 and obesity due to melanocortin 4 receptor deficiency.